Skip to main content
. 2014 Jan 22;9(1):e86091. doi: 10.1371/journal.pone.0086091

Figure 1. Effect of ASM-024 on cellular inflammation.

Figure 1

ASM-024 was administered by (A) nebulization of a solution and (B) orally to OVA-sensitized mice. A dose-related inhibition of inflammation is observed, no further inhibitory effect observed at a dose higher than 10 mg/kg p.o.; Values are mean ± SD. * Significantly different from vehicle control groups; p≤0.001; n = 8–9; ED50 p.o. = 3.55 mg/kg; ED50 inhalation = 0.03 mg/kg.